INTRODUCTION
Mesenchymal tumors of the uterus with cytological and architectural features reminiscent of endometrial stromal cells are classified as endometrial stromal tumors (EST).
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The recent World Health Organization Classification of Tumors of the Breast and Female Genital Organs divides the uterine stromal neoplasms into three groups: (i) benign endometrial stromal nodule (ESN); (ii) low-grade endometrial stromal sarcoma (LGESS); (iii) undifferentiated endometrial sarcoma. 2 Among the ESTs, Endometrial stromal sarcoma (ESS) is the commonest, accounting for 0.2-1% of all uterine malignancies and 6-20% of all uterine sarcomas. Distinguishing LGESS from benign smooth muscle proliferations like cellular leiomyoma can be challenging, but because of differing treatment and prognosis, this distinction is important. Its clinical recognition may be difficult and the diagnosis is often made postoperatively after histopathological examination. Preoperative diagnosis is mostly a uterine fibroid.
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Although the presence of an EST is sometimes established by curettage, a definitive diagnosis of LGESS can be made if myometrial and/or vascular invasion is identified in the tissue fragments. Nevertheless, a hysterectomy is usually required to permit the thorough evaluation of the tumor margin which is necessary to distinguish a stromal sarcoma from a benign stromal nodule. 5 Due to its rarity, ESS has only been reported in a few studies, and these were limited to case reports or retrospective analysis based on a small number of patients. By this study, we have attempted to document the histologic features of LGESS with discussion of the differential diagnoses to contribute to this rare spectrum of uterine neoplasms.
CASE SERIES
We report a series of 4 cases of low grade endometrial stromal sarcoma reported within a 5 year periodbetween 2010 to 2015. The salient clinical details of all the cases are highlighted in Table 1 .
All four cases were clinically diagnosed as fibroid uterus. In two of the young patients, myomectomy was performed, which was later followed up with total abdominal hysterectomy with bilateral salphingo-oopherectomy after a diagnosis of ESS was made on the myomectomy specimens.
The ultrasound examination in all cases were reported as suggestive of large intramural fibroids.
In all four of our cases, the tumor size was large ranging from 15 to 25 cm in greatest dimension. All were solitary , well delineated , predominantly intramural tumors. The cut surface ranged from pale white to pale yellow, fleshy with bulging cut surface, unlike the classical white firm whorled cut surface of leiomyoma ( fig.1 ). In one case the tumor was seen permeating the myometrium as infiltrating cords.
Microscopically all cases showed a densely cellular tumor composed of uniform oval to spindle cells bearing a close resemblance to normal endometrial stromal cells. Tumor cells were seen arranged around spiral arteriole like vessels. 
DISCUSSION
Endometrial stromal tumors are rare uterine malignancies composed of cells resembling those of proliferative endometrial stroma. They are subdivided into benign and malignant groups based on the type of tumor margin. Those with pushing margins are benign stromal nodules, while those with infiltrating margins are stromal sarcomas. Endometrial stromal sarcomas were previously subdivided into low or high grade categories depending upon mitotic index but now the latter are termed poorly differentiated or undifferentiated uterine sarcoma due to its aggressive clinical course. 2 LGESS usually affects women in the pre and perimenopausal age groups, with a median age being 45 and 57 years.But in our study, two of our cases were young women aged 26 and 32 respectively. Symptoms at presentation include abnormal vaginal bleeding, progressive menorrhagia and abdominal pain as seen in our cases. 3 Preoperatively they are most commonly misdiagnosed as fibroid uterus and managed accordingly. 6 The pathogenesis of these lesion remains unknown, but exposures to tamoxifen and unopposed estrogens or prior irradiation have been implicated in some cases. At presentation, extrauterine pelvic extension, most commonly involving the ovary, is found in up to 1/3 of patients.
LGESS show neoplastic stromal cells resembling those of Distinguishing LGESS from benign smooth muscle proliferations like cellular leiomyoma can be challenging, especially since ESS can show areas of smooth muscle differentiation. Fascicular areas, thick walled blood vessels and cleft-like spaces in cellular leiomyoma, more often seen at the periphery of the tumor are the features which differentiate it with LGESS. In uncertainty, antibodies to smooth muscle myosin-heavy chain, CD10, calponin, smooth muscle actin and desmin can reliably distinguish 3 In a study of 113 cases of low-grade endometrial stromal sarcomas by Chang KL et al, mitotic activity and cytological atypia were not found to be predictive of tumor recurrence in stage I tumors, while size correlated poorly with outcome as tumors <4 cm in diameter also recurred. For the patients at stage I, overall 5 year survival was reported to be 94.7%.
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CONCLUSION
Because of rarity of this tumor, diagnosis of LGESS is not frequently encountered in gynecological practice and hence awareness is essential. Since ultrasound and MRI studies are inconclusive, frequently it could be mistaken for a fibroid and managed conservatively with myomectomy especially in a younger woman. Hence a high index of suspicion is required to make a correct preoperative diagnosis so that a properly planned management of the patient can be carried out.
